TAILIEUCHUNG - The Fuel Cell Industry Review 2012

Fuel Cell Today is the leading source of information and analysis covering the global market for fuel cells. The Fuel Cell Industry Review 2012 is the second edition of our annual publication which presents a global summary of developments in the fuel cell industry during the past four years, a forecast for the current year and an outlook for the future. The Current State of the Industry chapter covers developments during 2011 and the fi rst half of 2012, discussing each sub-application in turn, followed by regional developments and the latest update for each main fuel cell type. As discussed in. | FuelCellToday The leading authority on fuel cells The Fuel Cell Industry Review 2012 ACKNOWLEDGEMENTS Fuel Cell Today gratefully acknowledges the contribution of many individuals and companies within the fuel cell industry in providing information for and assistance with the compilation of the Fuel Cell Today Industry Review 2012. The Fuel Cell Today Industry Review 2012 is based for the most part on information available up to July 2012. COPYRIGHT DISCLAIMER Fuel Cell Today Industry Review 2012 is the copyright of Johnson Matthey PLC trading as Fuel Cell Today. Material from this publication may be reproduced without prior permission provided that Fuel Cell Today is acknowledged as the source. Johnson Matthey PLC endeavours to ensure the accuracy of the information and materials contained within this report but makes no warranty as to accuracy completeness or suitability for any particular purpose. Johnson Matthey PLC accepts no liability whatsoever in respect of reliance placed by the user on information and materials contained in this report which are utilised expressly at the user s own risk. In particular this report and the information and materials in this report are not and should not be construed as an offer to buy or sell or solicitation of an offer to buy or sell any regulated products securities or investments or making any recommendation or providing any investment or other advice with respect to the purchase sale or other disposition of any regulated products securities or investments including without limitation any advice to the effect that any related transaction is appropriate or suitable for any investment objective or financial situation of a prospective investor. A decision to invest in any regulated products securities or investments should not be made in reliance on any of the information or materials in this report. Before making any investment decision prospective investors should seek advice from their financial legal tax and accounting .

• Báo chí - Truyền thông
• Enzyme Therapy
• Follow up
• Principles and Strategies
• Monitoring Individuals
• Treatment Outcomes
• Coeliac Disease Diagnosed
• Chinese Medicine
• Venom Therapy
• Alternative Medicine
• Cooling Therapy
• Electromagnetic Therapy
• BMC Pharmacology and Toxicology
• Fabry disease
• Enzyme replacement therapy
• Including globotriaosylceramide
• Agalsidase beta
• Coronary Interventions
• Vascular Access
• Percutaneous Coronary
• Determination
• Nutritional and Proteomic
• Monitoring Individual
• Report medicine
• traditional medicine
• scientific reports
• tumor cells
• medical knowledge
• chemical reaction